Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia
Tóm tắt
Ischemic stroke is a leading cause of death and disability in developed countries. Yet, in spite of substantial research and development efforts, no specific therapy for stroke is available. Several mechnism for neuroprotection have been explored including ionchannels, excitatory amino acids and oxygen raicals yet none has culminated in an effective therapeutic effect. The review article on “inflammation and stroke” summarizes key data in support for the possibility that inflammatory cells and mediators are important contributing and confounding factors in ischemic brain injury. In particular, the role of cytokines, endothelial cells and leukocyte adhesion molecules, nitric oxide and cyclooxygenase (COX‐2) products are discussed. Furthermore, the potential role for certain cytokines in modulation of brain vulnerability to ischemia is also reviewed.The data suggest that novel therapeutic strategies may evolve from detailed research on some specific inflammatory factors that act in spatial and temporal relationships with traditionally recognized neurotoxic factors. The dual nature of some mediators in reformatting of brain cells for resistance or sensitivity to injury demonstrate the delicate balance needed in interventions based on anti‐inflammatory strategies.
Từ khóa
Tài liệu tham khảo
Chen H, 1992, Neutropenia reduces the volume of cerebral infarct after transient middle cerebral artery occlusion in the rat, Neurosci Res Commun, 11, 93
D'Souza S, 1995, Differential susceptibility of human CNS‐derived cell populations to TNF‐dependent and independent immune‐mediated injury, J Neurosci, 15, 7293, 10.1523/JNEUROSCI.15-11-07293.1995
Zoppo GJ, 1994, Microvascular changes during cerebral ischaemia and reperfusion, Cerebrovasc Brain Metab Rev, 6, 47
Zoppo GJ, 1996, Loss of α1β1 integrin immunoreactivity on cerebral microvessels and astrocytes following focal cerebral ischemia/reperfusion, Cerebrovasc Dis, 6, 9
Loreto S, 1997, Blockade of N‐methyl‐D‐aspartate receptor prevents hypoxic neuronal death and cytokine release, Neuroimmunomodulation, 4, 195, 10.1159/000097338
Eng LF, 1988, Biochemical Pathology of Astrocytes, 79
Feuerstein GZ, 1998, Cerebrovascular Disease: Pathophysiology, Diagnosis and Management, 507
Garcia JH, 1994, Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat), Am J Pathol, 144, 188
Goldblum SE, 1990, Tumour necrosis factor‐alpha augments pulmonary arterial transendothelial albumen flux in vitro, Am J Physiol, 285, L57
Goodman JC, 1990, Elevation of tumour necrosis factor in head injury, J Neuroimmunol, 30, 2
Gosh S, 1997, Lipid Biochemistry: Function of glycorolipids and sphingolipids in cellular singaling, FASEB J, 11, 45, 10.1096/fasebj.11.1.9034165
Iadecola C, 1997, Delayed reduction in ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene, J Neurosci, 17, 9157, 10.1523/JNEUROSCI.17-23-09157.1997
Iadecola C, 1995, Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage, Am J Physiol, 268, R286
Kogure K, 1996, Inflammation of the brain after ischemia, Acta Neurochir, 66, 40
Kontos CD, 1992, Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo, Am J Physiol, 263, H1234
Liu T, 2000, Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF‐α and ceramide, Am J Physiol (Cell Physiol)
Melillo G, 1996, Regulation of inducible nitric oxide synthase expression in IFN‐gamma‐ treated murine macrophages cultured under hypoxic conditions, J Immunol, 157, 2638, 10.4049/jimmunol.157.6.2638
Mori E, 1991, Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism, 137
O'Callaghan JP, 1991, Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker, Biomed Environ Sci, 4, 197
Okada Y, 1996, Integrin αvβ3 is expressed in selected microvessels following focal cerebral ischemia, Am J Pathol, 149, 37
Rothwell NJ, 1993, Involvement of interleukin‐1 and lipocortin‐1 in ischemic brain damage, Cerebrovas Brain Metab Rev, 5, 178
Seibert K, 1995, Mediation of inflammation by cyclooxygenase‐2, Agents and Actions Suppl, 46, 41
Smith RA, 1992, Characterization of TNF receptors, Immunol Se, 56, 149
Smith WL, 1995, Biochemistry of prostaglandin endoperoxide H synthase‐1 and synthase‐2 and their differential susceptibility to nonsteroidal antiinflammatory drugs, Sem Nephrol, 15, 179
Vodovotz Y, 1994, Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN‐gamma and bacterial lipopolysaccharide, J Immunol, 152, 4110, 10.4049/jimmunol.152.8.4110
Vourte J, 1999, Anti‐ICAM‐1 monoclonal antibody R65 (Enlimomab) promotes activation of neutrophils in whole blood, J Immunol, 162, 2353, 10.4049/jimmunol.162.4.2353
Zhao X, 1999, Gene‐dosing effect of reduction of ischemic brain injury in mice lacking the inducible nitric oxide synthase gene, Soc Neurosci Abstr, 25, 793